{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T22:03:00Z","timestamp":1746309780779,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00430-018-0549-y","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T12:07:07Z","timestamp":1530619627000},"page":"249-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Preventing vertical virus infections: the role of serologic screening of pregnant women"],"prefix":"10.1007","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-4290","authenticated-orcid":false,"given":"Annemarie","family":"Berger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Wilhelm","family":"Doerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"key":"549_CR1","unstructured":"WHO Fact Sheet Rubella, updated November 2017. \n                    http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/rubella\n                    \n                  . Accessed 3 Jul 2018"},{"key":"549_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jcv.2018.02.006","volume":"102","author":"C Vauloup-Fellous","year":"2018","unstructured":"Vauloup-Fellous C (2018) Standardization of rubella immunoassays. J Clin Virol 102:34\u201338","journal-title":"J Clin Virol"},{"key":"549_CR3","unstructured":"Robert-Koch-Institut (2010) \u00c4nderung der Empfehlungen zur Impfung gegen R\u00f6teln. Epidemiol Bull 32:322\u2013325. \n                    https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2010\/Ausgaben\/32_10.pdf?__blob=publicationFile\n                    \n                  . Accessed 3 Jul 2018"},{"key":"549_CR4","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Leitlinie: Labordiagnostik schwangerschaftsrelevanter Virusinfektionen. S2k-Leitlinie AWMF Registernummer 0093\/001 Stand: 31.03.2014. \n                    http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/093-001.html\n                    \n                  . Accessed 12 Feb 2018"},{"key":"549_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coviro.2017.10.003","volume":"27","author":"F Bonvicini","year":"2017","unstructured":"Bonvicini F. Bua G, Gallinella G (2017) Parvovirus B19 infection in pregnancy-awareness and opportunities. Curr Opin Virol 27:8\u201314","journal-title":"Curr Opin Virol"},{"key":"549_CR6","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/bmj.300.6733.1166","volume":"300","author":"Public Health Laboratory Service Working Party on Fifth Disease","year":"1990","unstructured":"Public Health Laboratory Service Working Party on Fifth Disease (1990) Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 300:1166\u20131170","journal-title":"BMJ"},{"key":"549_CR7","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/0002-9378(90)90681-V","volume":"163","author":"JF Rodis","year":"1990","unstructured":"Rodis JF, Quinn DL, Gary GW Jr, Anderson LJ (1990) Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol 163:1168\u20131171","journal-title":"Am J Obstet Gynecol"},{"key":"549_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s15010-010-0035-y","volume":"38","author":"C Reinheimer","year":"2010","unstructured":"Reinheimer C, Allwinn R, Doerr HW, Wittek M (2010) Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: evaluation of risk factors. Infection 38:381\u2013385","journal-title":"Infection"},{"key":"549_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jcv.2017.07.010","volume":"94","author":"R Barlinn","year":"2017","unstructured":"Barlinn R, Rollag H, Trogstad L et al (2017) High incidence of maternal parvovirus B19 infection in a large unselected population-based pregnancy cohort in Norway. J Clin Virol 94:57\u201362","journal-title":"J Clin Virol"},{"key":"549_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jcv.2011.03.012","volume":"51","author":"S Bredl","year":"2011","unstructured":"Bredl S, Plentz A, Wenzel JJ, Pfister H, M\u00f6st J, Modrow S (2011) False-negative serology in patients with acute parvovirus B19 infection. J Clin Virol 51:115\u2013120","journal-title":"J Clin Virol"},{"key":"549_CR11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S1701-2163(15)30390-X","volume":"36","author":"J Crane","year":"2014","unstructured":"Crane J, Mundle W, Boucoiran I et al (2014) Parvovirus B19 in pregnancy. J Obstet Gynaecol Can 36:1107\u20131116","journal-title":"J Obstet Gynaecol Can"},{"key":"549_CR12","first-page":"561","volume":"33","author":"H Matsuda","year":"2005","unstructured":"Matsuda H, Sakaguchi K, Shibasaki T, Takahashi H, Kawakami Y, Furuya K (2005) Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin. J Perinat Med 33:561\u2013563","journal-title":"J Perinat Med"},{"key":"549_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jama.2010.1206","volume":"304","author":"B Pasternak","year":"2010","unstructured":"Pasternak B, Hviid A (2010) Use of acyclovir, valacyclovir and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 304:859\u2013866","journal-title":"JAMA"},{"key":"549_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00430-006-0032-z","volume":"196","author":"A Sauerbrei","year":"2007","unstructured":"Sauerbrei A, Wutzler P (2007) Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: varicella-zoster virus infections. Med Microbiol Immunol 196:95\u2013102","journal-title":"Med Microbiol Immunol"},{"key":"549_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12879-017-2461-2","volume":"17","author":"M Wiese-Posselt","year":"2017","unstructured":"Wiese-Posselt M, Siedler A, Mankertz A et al (2017) Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany. BMC Infect Dis 17:356","journal-title":"BMC Infect Dis"},{"key":"549_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/jdv.13995","volume":"31","author":"RN Werner","year":"2017","unstructured":"Werner RN, Nikkels AF, Marinovi\u0107 B et al (2017) European consensus-based (S2k) guideline on the management of herpes zoster\u2014guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), part 1: diagnosis. J Eur Acad Dermatol Venereol 31:9\u201319","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"549_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00430-013-0298-x","volume":"202","author":"HW Doerr","year":"2013","unstructured":"Doerr HW (2013) Progress in VZV vaccination? Some concerns. Med Microbiol Immunol 202:257\u2013258","journal-title":"Med Microbiol Immunol"},{"key":"549_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00430-007-0036-3","volume":"196","author":"S Wicker","year":"2007","unstructured":"Wicker S, Rabenau HF, Gottschalk R, Doerr HW, Allwinn R (2007) Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, VZV, polio, HBV, HCV and HIV) in medical students. Med Microbiol Immunol 196:145\u2013150","journal-title":"Med Microbiol Immunol"},{"key":"549_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00063-010-1061-3","volume":"105","author":"M Wittek","year":"2010","unstructured":"Wittek M, Doerr HW, Allwinn R (2010) Varicella and herpes zoster. Part 1: virology, epidemiology, clinical picture, laboratory diagnostics. Med Klin (Munich) 105:334\u2013338","journal-title":"Med Klin (Munich)"},{"key":"549_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00430-003-0183-0","volume":"192","author":"S Buxbaum","year":"2003","unstructured":"Buxbaum S, Geers M, Gross G, Sch\u00f6fer H, Rabenau HF, Doerr HW (2003) Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed? Med Microbiol Immunol 192:177\u2013181","journal-title":"Med Microbiol Immunol"},{"key":"549_CR21","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(07)61908-4","volume":"370","author":"R Gupta","year":"2007","unstructured":"Gupta R, Warren T, Wald A (2007) Genital herpes. Lancet 370:2127\u20132137","journal-title":"Lancet"},{"issue":"1","key":"549_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.17.1.1-13.2004","volume":"17","author":"D Kimberlin","year":"2004","unstructured":"Kimberlin D (2004) Neonatal herpes simplex infection. Clin Microbiol Rev 17(1):1\u201313","journal-title":"Clin Microbiol Rev"},{"key":"549_CR23","first-page":"CD004946","volume":"1","author":"LM Hollier","year":"2008","unstructured":"Hollier LM, Wendel GD (2008) Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database Syst Rev 1:CD004946","journal-title":"Cochrane Database Syst Rev"},{"key":"549_CR24","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/jdv.12583","volume":"29","author":"M Pichler","year":"2015","unstructured":"Pichler M, Staffler A, Bonometti N, Messner H, Deluca J, Thuile T, Kluge R, Schmuth M, Eisendle K (2015) Premature newborns with fatal intrauterine herpes simplex virus-1 infection: first report of twins and review of the literature. J Eur Acad Dermatol Venereol 29:1216\u20131220","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"549_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00430-014-0346-1","volume":"203","author":"HW Doerr","year":"2014","unstructured":"Doerr HW, Berger A (2014) Vaccination against infectious diseases. What is promising? Med Microbiol Immunol 203:365\u2013371","journal-title":"Med Microbiol Immunol"},{"key":"549_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00430-009-0136-3","volume":"199","author":"PR L\u00fcbeck","year":"2010","unstructured":"L\u00fcbeck PR, Doerr HW, Rabenau HF (2010) Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol 199:53\u201360","journal-title":"Med Microbiol Immunol"},{"key":"549_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00430-012-0232-7","volume":"201","author":"G Enders","year":"2012","unstructured":"Enders G, Daiminger A, Lindemann L, Knotek F, B\u00e4der U, Exler S, Enders M (2012) Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996\u20132010. Med Microbiol Immunol 201:303\u2013309","journal-title":"Med Microbiol Immunol"},{"key":"549_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10096-014-2266-9","volume":"34","author":"M Rycel","year":"2015","unstructured":"Rycel M, Wujcicka W, Zawili\u0144ska B, Paradowska E, Suski P, Gaj Z, Wilczy\u0144ski J, Le\u015bnikowski Z, Nowakowska D (2015) Mixed infections with distinct cytomegalovirus glycoprotein B genotypes in Polish pregnant women, foetuses, and newborns. Eur J Clin Microbiol Infect Dis 34:585\u2013591","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"549_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00404-017-4380-2","volume":"296","author":"KO Kagan","year":"2017","unstructured":"Kagan KO, Hamprecht K (2017) Cytomegalovirus in pregnancy. Arch Gynecol Obstet 296:15\u201326","journal-title":"Arch Gynecol Obstet"},{"key":"549_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0166-0934(87)90075-9","volume":"17","author":"HW Doerr","year":"1987","unstructured":"Doerr HW (1987) Cytomegalovirus infection in pregnancy. J Virol Methods 17:127\u2013132","journal-title":"J Virol Methods"},{"key":"549_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00430-015-0399-9","volume":"204","author":"W Britt","year":"2015","unstructured":"Britt W (2015) Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy. Med Microbiol Immunol 204:263\u2013271","journal-title":"Med Microbiol Immunol"},{"key":"549_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jcv.2011.05.007","volume":"51","author":"A Berger","year":"2011","unstructured":"Berger A, Reitter A, Harter PN, Buxmann H, Allwinn R, Louwen F, Doerr HW (2011) Problems and challenges in the diagnosis of vertical infection with human cytomegalovirus (CMV): lessons from two accidental cases. J Clin Virol 51:285\u2013288","journal-title":"J Clin Virol"},{"key":"549_CR33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00430-016-0474-x","volume":"205","author":"HW Doerr","year":"2016","unstructured":"Doerr HW (2016) Fighting cytomegalovirus-caused diseases: the immunologic approach. Med Microbiol Immunol 205:511\u2013512","journal-title":"Med Microbiol Immunol"},{"issue":"6","key":"549_CR34","doi-asserted-by":"publisher","first-page":"e1937","DOI":"10.1542\/peds.2013-0076","volume":"131","author":"TM Lanzieri","year":"2013","unstructured":"Lanzieri TM, Dollard SC, Josephson CD, Schmid DS, Bialek SR (2013) Breast milk-acquired cytomegalovirus infection and disease in very low birth weight and premature infants. Pediatrics 131(6):e1937\u2013e1945","journal-title":"Pediatrics"},{"key":"549_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00430-015-0427-9","volume":"205","author":"A Reitter","year":"2016","unstructured":"Reitter A, Buxmann H, Haberl AE, Schl\u00f6sser R, Kreibich M, Keppler OT, Berger A (2016) Incidence of CMV co-infection in HIV-positive women and their neonates in a tertiary referral centre: a cohort study. Med Microbiol Immunol 205:63\u201371","journal-title":"Med Microbiol Immunol"},{"key":"549_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/14767058.2013.806899","volume":"27","author":"N Wagner","year":"2014","unstructured":"Wagner N, Kagan KO, Haen S, Schmidt S et al (2014) Effective management and intrauterine treatment of congenital cytomegalovirus infection: review article and case series. J Matern Fetal Neonatal Med 27:209\u2013214","journal-title":"J Matern Fetal Neonatal Med"},{"key":"549_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00430-017-0512-3","volume":"206","author":"V Seidel","year":"2017","unstructured":"Seidel V, Feiterna-Sperling C, Siedentopf JP, Hofmann J et al (2017) Intrauterine therapy of cytomegalovirus infection with valganciclovir: review of the literature. Med Microbiol Immunol 206:347\u2013354","journal-title":"Med Microbiol Immunol"},{"issue":"9","key":"549_CR38","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/apa.13959","volume":"106","author":"W Rawlinson","year":"2017","unstructured":"Rawlinson W (2017) Congenital CMV international guidelines are needed to guide diagnosis, prevention and management. Acta Paediatr 106(9):1389\u20131390","journal-title":"Acta Paediatr"},{"key":"549_CR39","unstructured":"Hamprecht K, Kagan KO, Schampera M, Jahn G (2018) Impact of pharmacokinetics on the efficiency of CMV-specific hyperimmune globulin treatment in early CMV-primary infection during pregnancy (abstract). In: 28th annual meeting of the Society for Virology, March 14\u201317, W\u00fcrzburg, OP 137"},{"key":"549_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00430-015-0388-z","volume":"204","author":"S Plotkin","year":"2015","unstructured":"Plotkin S (2015) The history of vaccination against cytomegalovirus. Med Microbiol Immunol 204:247\u2013254","journal-title":"Med Microbiol Immunol"},{"key":"549_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00430-015-0392-3","volume":"204","author":"ES Mocarski","year":"2015","unstructured":"Mocarski ES (2015) Stanley Plotkin: the bright spark of cytomegalovirus vaccines. Med Microbiol Immunol 204:243\u2013245","journal-title":"Med Microbiol Immunol"},{"key":"549_CR42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00430-016-0472-z","volume":"205","author":"B Plachter","year":"2016","unstructured":"Plachter B (2016) Prospects a vaccine for the prevention of congenital cytomegalovirus disease. Med Microbiol Immunol 205:537\u2013547","journal-title":"Med Microbiol Immunol"},{"key":"549_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.14218\/JCTH.2016.00067","volume":"5","author":"MG Mavilia","year":"2017","unstructured":"Mavilia MG, Wu GY (2017) Mechanisms and prevention of vertical transmission in chronic viral hepatitis. J Clin Transl Hepatol 5:119\u2013129 (Review)","journal-title":"J Clin Transl Hepatol"},{"key":"549_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11904-014-0198-8","volume":"11","author":"F Nakagawa","year":"2014","unstructured":"Nakagawa F, Phillips AN, Lundgren JD (2014) Update on HIV in Western Europe. Curr HIV\/AIDS Rep 11:177\u2013185 (Review)","journal-title":"Curr HIV\/AIDS Rep"},{"key":"549_CR45","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/tmi.13014","volume":"23","author":"AC Vrazo","year":"2018","unstructured":"Vrazo AC, Firth J, Amzel A, Sedillo R, Ryan J, Phelps BR (2018) Interventions to significantly improve service uptake and retention of HIV-positive pregnant women and HIV-exposed infants along the PMTCT continuum of care. A systematic review. Trop Med Int Health 23:136\u2013148","journal-title":"Trop Med Int Health"},{"key":"549_CR46","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12072-017-9825-y","volume":"11","author":"JS Park","year":"2017","unstructured":"Park JS, Pan CQ (2017) Viral factors for HBV mother-to-child transmission. Hepatol Int 11:476\u2013480","journal-title":"Hepatol Int"},{"key":"549_CR47","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/00365521.2016.1244704","volume":"52","author":"N Weis","year":"2017","unstructured":"Weis N, Cowan S, Hallager S, Dr\u00f6se S et al (2017) Vertical transmission of hepatitis B virus during pregnancy and delivery in Denmark. Scand J Gastroenterol 52:178\u2013184","journal-title":"Scand J Gastroenterol"},{"key":"549_CR48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/23744235.2017.1384957","volume":"50","author":"S Tavakolpour","year":"2018","unstructured":"Tavakolpour S, Darvishi M, Mirsafaei HS, Ghasemiadl M (2018) Nucleoside\/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review. Infect Dis (Lond) 50:95\u2013106","journal-title":"Infect Dis (Lond)"},{"key":"549_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00430-014-0373-y","volume":"204","author":"WH Gerlich","year":"2015","unstructured":"Gerlich WH (2015) Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immunol 204:39\u201355","journal-title":"Med Microbiol Immunol"},{"key":"549_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00430-014-0374-x","volume":"204","author":"D Shouval","year":"2015","unstructured":"Shouval D. Roggendorf H, Roggendorf M (2015) Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1\/Pre-S2\/S vaccine. Med Microbiol Immunol 204:57\u201368","journal-title":"Med Microbiol Immunol"},{"key":"549_CR51","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/erv.13.44","volume":"12","author":"HW Doerr","year":"2013","unstructured":"Doerr HW (2013) Perspectives of vaccination in adults. Expert Rev Vaccines 12:593\u2013596","journal-title":"Expert Rev Vaccines"},{"key":"549_CR52","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. S2k Leitlinie: Deutsch-\u00d6sterreichische Leitlinie zur HIV-Therapie in der Schwangerschaft und bei HIVexponierten Neugeborenen. AWMF-Register-Nr.: 055-002 Stand M\u00e4rz 2017. \n                    http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/055-002l_S2k_HIV-Therapie_Schwangerschaft_Neugeborenen_2017-07.pdf\n                    \n                  . Accessed 3 Jul 2018"},{"key":"549_CR53","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. S2k Leitlinie: Leitlinien zur antiretroviralen Therapie bei Kindern und Jugendlichen. AWMF-Register-Nr.: 048-011 Klassifikation: S1 Version 03_2013 Stand 17.03.2013. \n                    http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/048-011l_S1_Antiretroviralen_Therapie_bei_Kindern_und_Jugendlichen_03-2013-abgelaufen.pdf\n                    \n                  . Accessed 3 Jul 2018"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-018-0549-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-018-0549-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-018-0549-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T19:22:09Z","timestamp":1562095329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-018-0549-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":53,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1007\/s00430-018-0549-y","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"type":"print","value":"0300-8584"},{"type":"electronic","value":"1432-1831"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"12 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}